ATLANTA--(BUSINESS WIRE)-- #earnings--Crawford & Company® (NYSE: CRD-A and CRD-B), is pleased to announce its financial results for the second quarter ended June 30, 2025. Revenues before reimbursements increased 3% to $323.0 million in the 2025 second quarter from $314.2 million in the 2024 second quarter. Second quarter net income was $7.8 million, or $0.16 per diluted share for CRD-A and CRD-B, compared to $8.6 million, or $0.17 per diluted share for CRD-A and CRD-B in the prior year quarter. GAAP C
Related Questions
How did the company's performance compare to its main competitors in the consulting and risk management sector?
How does the 3% revenue growth compare to consensus analysts' expectations for Q2 2025?
What are the underlying reasons for the decline in net income and EPS despite revenue growth?
Are there any notable changes in operating expenses, SG&A, or EBITDA that could affect profitability?
What are the cash flow and free cash flow results for the quarter?
What are the potential risks or catalysts that could affect the stock price in the short term?
What is the current valuation multiple (P/E, EV/EBITDA) after the earnings release?
Are there any significant one-time items or non-recurring charges influencing the results?
Did the company provide any updated guidance or outlook for the full year 2025?
How did the company's earnings per share trend versus market expectations?
How does the company's ROE and ROA performance compare to the prior year?
Is there any indication of upcoming acquisitions, divestitures, or restructuring?
What is the current dividend policy and any changes announced?
What is the impact of any changes in reimbursement rates on the revenue figure?
What were the GAGA (GAAP) margins and how do they compare to the prior quarter and year?